1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
CVOT Summit Report 2023 : new cardiovascular, kidney, and metabolic outcomes
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Factors influencing hospitalization or emergency department visits and mortality in type 2 diabetes following the onset of new cardiovascular diagnoses in a population-based study
(
- Contribution to journal › Article
-
Mark
The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice
(
- Contribution to journal › Article
-
Mark
DNA methylation risk score for type 2 diabetes is associated with gestational diabetes
(
- Contribution to journal › Article
-
Mark
Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction : a nationwide observational study
(
- Contribution to journal › Article
-
Mark
Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes : the SUCRE study
(
- Contribution to journal › Article
- 2023
-
Mark
Different roles of protein biomarkers predicting eGFR trajectories in people with chronic kidney disease and diabetes mellitus : a nationwide retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals—a Swedish population-based study
(
- Contribution to journal › Article
- 2022
-
Mark
Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity : the Malmö Preventive Project
(
- Contribution to journal › Article
-
Mark
Polygenic scores for low lung function and the future risk of adverse health outcomes
(
- Contribution to journal › Article